FSI 8-K
Flexible Solutions International Inc (FSI)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date
of Report (date of earliest event reported):
(Exact name of Registrant as specified in its charter)
| Alberta | 71 163 0889 | |||
(State or other jurisdiction of incorporation) |
(Commission File No.) |
(Employer Identification No.) |
(Address of principal executive offices, including Zip Code)
Registrant’s
telephone number, including area code:
N/A
(Former name or former address if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§203.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§204.12b-2 of this chapter.
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On August 31, 2026:
John Bientjes resigned as a director of the Company and as the chairman of the Company’s audit committee.
Dr. Kim Reid was appointed a director of the Company and as a member of the Company’s audit committee.
Davis Fynn was appointed as a chairman of the audit committee.
The resignation of Mr. Bientjes was not due to any disagreement on any matter relating to the Company’s operations, policies, or practices.
| Item 8.01 | Other Events |
On August 31, 2026, the Company issued a press release announcing the resignation of Mr. Bientjes as a director and the appointment of Mr. Reid as a director.
| Item 9.01 | Exhibits |
Exhibit Number |
Description of Document | |
| 99.1 | August 31, 2026 Press Release | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: | September 1, 2026 | FLEXIBLE SOLUTIONS INTERNATIONAL INC. | |
| By: | /s/ Daniel B. O’Brien | ||
| Daniel B. O’Brien, President and Chief Executive Officer | |||
| 3 |
EXHIBIT 99.1
| NEWS RELEASE | August 31, 2026 |
FSI announces the appointment of Dr. Kim Reid as director
TABER, ALBERTA, August 31, 2026– FLEXIBLE SOLUTIONS INTERNATIONAL, INC. (NYSE-AMERICAN: FSI), is the developer and manufacturer of biodegradable polymers for oil extraction, detergent ingredients and water treatment as well as crop nutrient availability chemistry. Flexible Solutions also manufactures biodegradable and environmentally safe water and energy conservation technologies. In addition, FSI is increasing its presense in the food and nutrition supplement manufacturing markets. Today the Company wishes to announce the appointment of Dr. Kim Reid as director and audit committee member.
“The Board of Directors wishes to announce the resignation of Director John Bientjes after nearly thirty years of service. We are sad to lose his official advice but, John will remain as a friend and confidant of the Company. Mr. Bientjes also served as Audit Committee Chair; Mr. David Fynn, who has been on the Audit Committee for many years, has accepted the Audit Committee Chair position.
We are also pleased to announce the appointment of Dr. Kim Reid as Director and Audit Committee member, to serve until the next Annual Meeting. Dr. Reid is a process development scientist with a background in bio-manufacturing, molecular biology, health research, and operational leadership. She is currently a Postdoctoral Fellow in the John C. Bell Laboratory at the Ottawa Hospital Research Institute, where she leads a technology transfer team to bring mRNA-LNP cancer-vaccine production from academia into scaled GMP bio-manufacturing. She has experience in upstream and downstream process development, assay development, quality control and assurance, GMP clean-room procedures, bioreactors, filtration, chromatography and fill-and-finish. She holds a PhD in Biology from the University of Ottawa, an MSc in Experimental Pathology and Laboratory Medicine from UBC, an Advanced Biotechnology Diploma from Algonquin College, a BSc in Biology, and a combined BSc in Physics and Physical Oceanography. She has completed specialized training in GMP and mRNA/mRNA-LNP biomanufacturing.
Kim’s research has been published in peer-reviewed journals including Scientific Reports, Journal of Biological Chemistry, and Endocrinology, and her work as a freelance systematic reviewer has involved leading multidisciplinary teams in the examination of clinical and health-economics evidence for international clients. Her current professional engagement includes founding and leading the Expert Talk Series for the Society for RNA Therapeutics. Early in her career, Kim served with the Royal Canadian Air Force as an officer and fighter pilot, flying the CT-114 Tutor, CF-5 Freedom Fighter and CF-18 Hornet with 441 Tactical Fighter Squadron. She was the third woman to fly fighter aircraft in Canada and the first woman to become operationally qualified for both NORAD and NATO combat missions. Her experience will allow her to contribute to scientific and board discussions, particularly where technology, innovation, risk, regulated environments, evidence-based decision-making and organizational leadership intersect.
We are excited to welcome Dr. Reid and feel sure that she will add depth and new skills to the Board.
Once again, we would like to thank John personally for all his years of service and friendship.”
| 1 |
About Flexible Solutions International
Flexible Solutions International, Inc. (www.flexiblesolutions.com), based in Taber, Alberta, is an environmental technology company. The Company’s NanoChem Solutions Inc. subsidiary specializes in biodegradable, water-soluble products utilizing thermal polyaspartate (TPA) biopolymers. TPA beta-proteins are manufactured from the common biological amino acid, L-aspartic and have wide usage including scale inhibitors, detergent ingredients, water treatment and crop enhancement. Along with TPA, this division started producing other crop enhancement products as well. In 2022, the Company entered the food and nutrition markets by obtaining FDA food grade approval for the Peru IL plant. The other divisions manufacture energy and water conservation products for drinking water, agriculture, industrial markets and swimming pools throughout the world.
Safe Harbor Provision
The Private Securities Litigation Reform Act of 1995 provides a “Safe Harbor” for forward-looking statements. Certain of the statements contained herein, which are not historical facts, are forward looking statement with respect to events, the occurrence of which involve risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company is detailed from time to time in the company’s reports filed with the Securities and Exchange Commission.
Flexible Solutions International
6001 54th Ave, Taber, Alberta, CANADA T1G 1X4
Company Contacts
Jason Bloom
Toll Free: 800.661.3560
Fax: 403.223.2905
Email: [email protected]
To find out more information about Flexible Solutions and our products please visit www.flexiblesolutions.com
If you have received this news release by mistake or if you would like to be removed from our update list please reply to: [email protected]
| 2 |